Abstract
Evidence exists that a norepinephrine/prostaglandin E2 (PGE2)/cAMP pathway is involved in the regulation of luteinizing hormone-releasing hormone (LHRH) secretion. The aim of the present experiments was to determine if release of LHRH from the immature rat hypothalamus could also be stimulated by activation of protein kinase C. Median eminences from 28-day-old female rats were incubated in vitro with either dioctanoylglycerol (a synthetic diacylglycerol that selectively activates protein kinase C in intact cells) or 4 beta-phorbol 12 beta-myristate 13 alpha-acetate (another protein kinase C activator). Both agents increased LHRH release, the response to dioctanoylglycerol being more pronounced than that to the phorbol ester. This direct activation of protein kinase C was not accompanied by changes in PGE2 formation. Activation of the PGE2/cAMP pathway by either norepinephrine, PGE2, or forskolin (a stimulator of adenylate cyclase) increased LHRH release. Dioctanoylglycerol or phorbol ester in conjunction with either norepinephrine, PGE2 or forskolin resulted in an additive effect on LHRH release suggesting coexistence of both pathways. Phospholipase C, which activates protein kinase C via formation of diacylglycerol, increased the release of both LHRH and PGE2. This suggests that an increase in endogenous phospholipase C activity caused by neurotransmitter inputs may lead to both activation of protein kinase C and PGE2 formation. Blockade of cyclooxygenase activity by indomethacin obliterated phospholipase C-induced PGE2 release. The same treatment reduced the LHRH response by only 50% indicating that protein kinase C activation can cause LHRH release in the absence of PGE2 synthesis. It is suggested that the median eminence of the rat possesses a protein kinase C-dependent pathway that is coupled positively to LHRH release and complements PGE2/cAMP-dependent mechanisms. Norepinephrine, however, does not appear to be the neurotransmitter responsible for activating the protein kinase C pathway. Simultaneous activation of both pathways may provide a mechanism by which a large increase in LHRH secretion occurs, such as in the afternoon of first proestrus.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baraban J. M., Gould R. J., Peroutka S. J., Snyder S. H. Phorbol ester effects on neurotransmission: interaction with neurotransmitters and calcium in smooth muscle. Proc Natl Acad Sci U S A. 1985 Jan;82(2):604–607. doi: 10.1073/pnas.82.2.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berridge M. J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J. 1983 Jun 15;212(3):849–858. doi: 10.1042/bj2120849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blumberg P. M., Jaken S., König B., Sharkey N. A., Leach K. L., Jeng A. Y., Yeh E. Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands. Biochem Pharmacol. 1984 Mar 15;33(6):933–940. doi: 10.1016/0006-2952(84)90448-9. [DOI] [PubMed] [Google Scholar]
- Cachelin A. B., de Peyer J. E., Kokubun S., Reuter H. Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature. 1983 Aug 4;304(5925):462–464. doi: 10.1038/304462a0. [DOI] [PubMed] [Google Scholar]
- Campbell W. B., Gomez-Sanchez C. E., Adams B. V. Role of prostaglandins in angiotensin-induced steriodogenesis absence of an effect by prostaglandin E2. Hypertension. 1980 Jul-Aug;2(4):471–476. doi: 10.1161/01.hyp.2.4.471. [DOI] [PubMed] [Google Scholar]
- Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
- Conn P. M., Ganong B. R., Ebeling J., Staley D., Neidel J. E., Bell R. M. Diacylglycerols release LH: structure-activity relations reveal a role for protein kinase C. Biochem Biophys Res Commun. 1985 Jan 16;126(1):532–539. doi: 10.1016/0006-291x(85)90638-2. [DOI] [PubMed] [Google Scholar]
- Exton J. H. Mechanisms involved in alpha-adrenergic phenomena. Am J Physiol. 1985 Jun;248(6 Pt 1):E633–E647. doi: 10.1152/ajpendo.1985.248.6.E633. [DOI] [PubMed] [Google Scholar]
- Gallardo E., Ramirez V. D. A method for the superfusion of rat hypothalami: secretion of luteinizing hormone-releasing hormone. Proc Soc Exp Biol Med. 1977 May;155(1):79–84. doi: 10.3181/00379727-155-39749. [DOI] [PubMed] [Google Scholar]
- Harris C. E., Staley D., Conn P. M. Diacylglycerols and protein kinase C. Potential amplifying mechanism for Ca2+-mediated gonadotropin-releasing hormone-stimulated luteinizing hormone release. Mol Pharmacol. 1985 May;27(5):532–536. [PubMed] [Google Scholar]
- Hartter D. E., Ramirez V. D. Responsiveness of immature versus adult male rat hypothalami to dibutyryl cyclic AMP- and forskolin-induced LHRH release in vitro. Neuroendocrinology. 1985 Jun;40(6):476–482. doi: 10.1159/000124118. [DOI] [PubMed] [Google Scholar]
- Kaibuchi K., Takai Y., Sawamura M., Hoshijima M., Fujikura T., Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem. 1983 Jun 10;258(11):6701–6704. [PubMed] [Google Scholar]
- Lapetina E. G., Reep B., Ganong B. R., Bell R. M. Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets. J Biol Chem. 1985 Feb 10;260(3):1358–1361. [PubMed] [Google Scholar]
- Martin T. F., Kowalchyk J. A. Evidence for the role of calcium and diacylglycerol as dual second messengers in thyrotropin-releasing hormone action: involvement of diacylglycerol. Endocrinology. 1984 Oct;115(4):1517–1526. doi: 10.1210/endo-115-4-1517. [DOI] [PubMed] [Google Scholar]
- McKelvy J. F., LeBlanc P., Laudes C., Perrie S., Grimm-Jorgensen Y., Kordon C. The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor. Biochem Biophys Res Commun. 1976 Nov 22;73(2):507–515. doi: 10.1016/0006-291x(76)90736-1. [DOI] [PubMed] [Google Scholar]
- Negro-Vilar A., Ojeda S. R., McCann S. M. Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. Endocrinology. 1979 Jun;104(6):1749–1757. doi: 10.1210/endo-104-6-1749. [DOI] [PubMed] [Google Scholar]
- Ohmura E., Friesen H. G. 12-O-tetradecanoyl phorbol-13-acetate stimulates rat growth hormone (GH) release through different pathways from that of human pancreatic GH-releasing factor. Endocrinology. 1985 Feb;116(2):728–733. doi: 10.1210/endo-116-2-728. [DOI] [PubMed] [Google Scholar]
- Ojeda S. R., Negro-Vilar A., McCann S. M. Evidence for involvement of alpha-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence. Endocrinology. 1982 Feb;110(2):409–412. doi: 10.1210/endo-110-2-409. [DOI] [PubMed] [Google Scholar]
- Ojeda S. R., Negro-Vilar A., McCann S. M. Release of prostaglandin Es by hypothalamic tissue: evidence for their involvement in catecholamine-induced luteinizing hormone-releasing hormone release. Endocrinology. 1979 Mar;104(3):617–624. doi: 10.1210/endo-104-3-617. [DOI] [PubMed] [Google Scholar]
- Ojeda S. R., Negro-Vilar A. Prostaglandin E2-induced luteinizing hormone-releasing hormone release involves mobilization of intracellular Ca+2. Endocrinology. 1985 May;116(5):1763–1770. doi: 10.1210/endo-116-5-1763. [DOI] [PubMed] [Google Scholar]
- Ojeda S. R., Urbanski H. F., Katz K. H., Costa M. E. Stimulation of cyclic adenosine 3',5'-monophosphate production enhances hypothalamic luteinizing hormone-releasing hormone release without increasing prostaglandin E2 synthesis: studies in prepubertal female rats. Endocrinology. 1985 Sep;117(3):1175–1178. doi: 10.1210/endo-117-3-1175. [DOI] [PubMed] [Google Scholar]
- Ramirez V. D., Kim K., Dluzen D. Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies. Recent Prog Horm Res. 1985;41:421–472. doi: 10.1016/b978-0-12-571141-8.50014-7. [DOI] [PubMed] [Google Scholar]
- Rasmussen H., Barrett P. Q. Calcium messenger system: an integrated view. Physiol Rev. 1984 Jul;64(3):938–984. doi: 10.1152/physrev.1984.64.3.938. [DOI] [PubMed] [Google Scholar]
- Seamon K. B., Daly J. W. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7(4):201–224. [PubMed] [Google Scholar]
- Siess W., Weber P. C., Lapetina E. G. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem. 1984 Jul 10;259(13):8286–8292. [PubMed] [Google Scholar]
- Takai Y., Kishimoto A., Iwasa Y., Kawahara Y., Mori T., Nishizuka Y. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem. 1979 May 25;254(10):3692–3695. [PubMed] [Google Scholar]
- Takai Y., Kishimoto A., Kawahara Y., Minakuchi R., Sano K., Kikkawa U., Mori T., Yu B., Kaibuchi K., Nishizuka Y. Calcium and phosphatidylinositol turnover as signalling for transmembrane control of protein phosphorylation. Adv Cyclic Nucleotide Res. 1981;14:301–313. [PubMed] [Google Scholar]
- Zawalich W., Brown C., Rasmussen H. Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun. 1983 Dec 16;117(2):448–455. doi: 10.1016/0006-291x(83)91221-4. [DOI] [PubMed] [Google Scholar]
